Thalassemia, a genetic blood disorder, has long been a challenge in the medical world. But with the advent of stem cell therapy, there’s a new ray of hope for patients. At Cell LaVie, we’re at the forefront of this groundbreaking treatment, offering new possibilities for those affected by this condition....
The human liver is a remarkable organ, known for its unique ability to regenerate itself. This ability, however, has its limits, particularly in cases of severe damage or chronic diseases. The emerging field of stem cell therapy offers a new horizon in liver regeneration. In this article, we’ll explore the...
The field of regenerative medicine has witnessed remarkable advancements in recent years, particularly in the area of cartilage regeneration using stem cells. Cartilage damage, often caused by diseases like osteoarthritis or injuries, has been a significant challenge in orthopedic medicine due to the limited self-healing capacity of cartilage. However, stem...
In the realm of regenerative medicine, mesenchymal stem cells (MSCs) have emerged as a beacon of hope for treating a variety of degenerative diseases. These cells, known for their unique ability to differentiate into various cell types, are at the forefront of some of the most promising advances in medical...
Glaucoma is one of the leading causes of blindness worldwide, and vision loss, due to the loss of retinal ganglion cells (RGCs), cannot currently be reversed with any treatment. Some studies have looked at replacing RGCs through cell transplants, but this process is still in the research and development stage...
Researchers have discovered that IL1 promotes the clonal expansion of TET2 knockout cells in blood, enhancing their self-renewal and myeloid bias, which is linked to an increased risk of leukemia and cardiovascular disease.
A trial conducted by teams from various universities and hospitals, including the University of Cambridge, has shown promising results in treating progressive multiple sclerosis with stem cells derived from brain tissue. The study observed no treatment-related deaths or serious adverse events over 12 months, and patients showed a substantial stability...
English 
Chinese 
Russian 
French